| 期 |
栏目 |
标题 |
文件 |
| 卷 92, 编号 6 (2020) |
Original articles |
New opportunities of renal denervation |
(Rus)
|
| 卷 93, 编号 1 (2021) |
Original articles |
Telomere length as a biomarker of the risk of cardiovascular complications in patients with coronary heart disease |
(Rus)
|
| 卷 93, 编号 3 (2021) |
Original articles |
Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension |
(Rus)
|
| 卷 93, 编号 4 (2021) |
Original articles |
Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis |
(Rus)
|
| 卷 93, 编号 4 (2021) |
History of medicine |
From palpation of the pulse to cuff-free methods: evolution of arterial pressure measurement methods |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Editorial |
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Consensuns |
Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Original articles |
Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Clinical notes |
The clinical case of successful combined treatment of refractory arterial hypertension. Case report |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Reviews |
Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Reviews |
Heart failure and obesity |
(Rus)
|
| 卷 93, 编号 12 (2021) |
Original articles |
The assessment of renal function during the therapy of arterial hypertension with azilsartan medoxomil in patients with obesity or overweight and concomitant metabolic disorders |
(Rus)
|
| 卷 94, 编号 1 (2022) |
Original articles |
Treatment of patients with arterial hypertension in clinical practice in 2010–2020 (according to the national register of hypertension) |
(Rus)
|
| 卷 94, 编号 7 (2022) |
Original articles |
Seх differences in treatment of acute coronary syndrome patients. Data from federal registry of acute coronary syndrome 2016–2019 |
(Rus)
|
| 卷 94, 编号 7 (2022) |
Original articles |
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry) |
(Rus)
|
| 卷 94, 编号 7 (2022) |
Reviews |
Rehabilitation in patients with chronic thromboembolic pulmonary hypertension |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Consensuns |
"Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism |
(Rus)
|
| 卷 95, 编号 1 (2023) |
Original articles |
Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy “escape” phenomenon |
(Rus)
|
| 卷 95, 编号 12 (2023) |
Reviews |
Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review |
(Rus)
|
| 卷 96, 编号 7 (2024): VARIO |
Editorial |
Diagnosis and management of patients with pheochromocytoma/paraganglioma: Consensus of experts of the Russian Medical Society for Arterial Hypertension and the Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors |
(Rus)
|
